Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Life Sciences

TEVA Pharma
Analysts Life Sciences TEVA
This pharma stock “is beating everything”, investor says

BNN Bloomberg Market Call guest Colin Cieszynski said Teva Pharmaceutical Industries (Teva Pharmaceutical Industries Stock Quote, Chart, News, Analysts, Financials NYSE:TEVA) has emerged as a standout performer amid a broader rotation into drug stocks, driven by strong price momentum and relative strength rather than company-specific catalysts. Speaking on the Jan. 9 program, the SIA Wealth […]

TLT stock
Analysts Life Sciences tlt
You should know this tiny Canadian biotech stock, analyst says

Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.70 target price on Theralase (Theralase Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:TLT) in a Jan. 12 update following the company’s announcement of a new clinical collaboration with Ferring Pharmaceuticals. Theralase said it has entered into a collaborative clinical development agreement with Ferring […]

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

Yesterday, TSO3 (TSX:TOS) announced that the US Regulatory Agency requested more information about i...

IMRIS CEO David Graves. On Friday, Byron Capital Healthcare Analyst Douglas Loe reiterated his BUY rating and $8 target on the stock.

On Thursday, IMRIS (TSX:IM) reported its Q4 and fiscal 2011 results. Across the board, the numbers w...

Titan Medical President Reiza Rayman. The company says the current market for robotic surgery is about $1 billion now, but will grow to $5 billion by 2015.

Investment themes come and go. Whether it’s internet advertising sending your daily hometown n...

Dr. Yves Fradet, President of Diagnocure. On Wednesday, Byron Capital analyst Douglas Loe upgraded the company to Buy from Speculative Buy because he says Diagnocure is no longer as subject to clinical or regulatory risk.

This past Wednesday DiagnoCure (TSX:CUR), along with its US-based partner Gen-Probe, received FDA ap...

Dacryocytes, or teardrop-shaped cells, are found in myelofibrosis and myelophthisic states of bone marrow. Mississauga's YM Bioscience's Myelofibrosis treatment, CYT387, has performed well in Phase Two trials. Byron Capital Healthcare analyst Douglas Loe thinks this may soon attract a larger

Last Thursday, YM Biosciences (TSX:YM) reported its Q2, 2012 results. The company lost $6.55-million...

Monique Champagne, Bioniche Life Sciences VP, Clinical Research and Graeme McRae, the company's CEO accept an Accolades 2011 Award of Excellence for High Technology and Innovation from The West Island of Montreal Chamber of Commerce on May 26, 2011.

A cursory glance at a three-year chart of Belleville’s Bioniche Life Sciences (TSX:BNC) illust...

Market research firm Global Industry Analysts says the global market for 3D medical imaging will reach (US) $5.9 Billion by 2017.

2008 was supposed to be Medipattern’s (TSXV:MKI) big year. The Toronto based company, which de...

Protech

Shares of CardioComm (TSXV:EKG) were on fire today after the company announced it had cleared an imp...

If you want telecom you go to Ottawa. If you want oil and gas technology, go to Alberta. When it com...

Neptune Technologies

Neptune Technologies (TSXV:NTB) yesterday reported its Q3, 2012 results. The numbers appeared to be ...

In combination with Gemzar, a nucleoside used in chemotherapy and marketed by Eli Lilly, eight of thirteen patients enrolled in a recent REOLYSIN study showed stability for twelve weeks or more.

The long and winding road. Investors know progress in biotech can be painfully slow. Oncolytics Biot...

Could Quebec's CAE Inc. eventually become as well know for its medical simulation technologies as its flight simulators?

CAE Inc. (TSX:CAE), which was founded in 1947 in Saint-Hubert, Quebec has built a billion dollar bus...

Dr. Lars Ekman, Executive Chairman and President of Protox Therapeutics. Byron Capital Healthcare and Biotech Analyst Douglas Loe believes the market is

In a recent note to clients, Byron Capital’s Healthcare and Biotech Analyst Douglas Loe reiter...

A map of canola production regions in Canada. Canada produces 20 percent of the world’s canola.

For Bioexx (TSX:BXI) shareholders, 2011 was a year to forget. Shuffling management, delays in bringi...

After a tough few years, the first half of 2011 showed signs of hope for shareholders of AEterna Zen...

With another remarkable year of revenue growth, can SXC Health's Mark Thierer repeat as Cantech Letter's Tech Stock Exec of the Year in 2011?

SXC Health’s (TSX:SXC) meteoric rise, accomplished primarily through acquisition, has been not...

There are many people who believe Canadian technology stocks are undervalued. Of course, as John May...

For Vancouver’s Verisante (TSXV:VRS), the waiting game is almost over. The company’s ski...

Share Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
MDA stock

Why MDA Space is worth more than you think

 January 20, 2026
RIOT stock

This crypto stock just won a big price target raise

 January 20, 2026

Small cap stocks will rule 2026, this analyst says

 January 20, 2026
VRNO stock

This pot stock is undervalued, Beacon says

 January 19, 2026
Pot stocks 2026

Will pot stocks rebound in 2026?

 January 16, 2026